The independent relationship between triglycerides and coronary heart disease

References

• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA200128524869711368702
   PubMed Web of Science ®Google Scholar
• British Cardiac Society, British Hypertension Society, Diabetes UKJBS 2: Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical practiceHeart200591Suppl 5v15216365341
   PubMed Web of Science ®Google Scholar
• ConroyRMPyoralaKFitzgeraldAPEstimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE projectEur Heart J200324987100312788299
   PubMed Web of Science ®Google Scholar
• Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary preventionEur Heart J19981914345039820987
   PubMedGoogle Scholar
• De BackerGAmbrosioniEBorch-JohnsenKEuropean guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical PracticeEur Heart J20032416011012964575
   PubMed Web of Science ®Google Scholar
• WoodDADurringtonPMcInnesGJoint British recommendations on prevention of coronary heart disease in clinical practiceHeart199880SupplS129
   PubMedGoogle Scholar
• Joint British recommendations on prevention of coronary heart disease in clinical practice: summary. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, British Diabetic AssociationBMJ2000320705810710586
   PubMed Web of Science ®Google Scholar
• HokansonJEAustinMAPlasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studiesJ Cardiovasc Risk19963213198836866
   PubMedGoogle Scholar
• AustinMAHokansonJEEdwardsKLHypertriglyceridemia as a cardiovascular risk factorAm J Cardiol1998814A7B2B9462597
   PubMed Web of Science ®Google Scholar
• Abdel-MaksoudMFHokansonJEThe complex role of triglycerides in cardiovascular diseaseSemin Vasc Med200223253316222622
   PubMedGoogle Scholar
• AvinsALNeuhausJMDo triglycerides provide meaningful information about heart disease risk?Arch Intern Med200016019374410888968
   PubMedGoogle Scholar
• AssmannGSchulteHRelation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster studyAm J Cardiol19927073371519522
   PubMed Web of Science ®Google Scholar
• AssmannGSchulteHvon EckardsteinAHypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged menAm J Cardiol1996771179848651092
   PubMed Web of Science ®Google Scholar
• AssmannGCullenPSchulteHSimple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) studyCirculation20021053101511804985
   PubMed Web of Science ®Google Scholar
• BaintonDMillerNEBoltonCHPlasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease StudiesBr Heart J1992686061355351
   PubMedGoogle Scholar
• BosGDekkerJMNijpelsGHoorn Study. A combination of high concentrations of serum triglyceride and non-high-density-lipoprotein-cholesterol is a risk factor for cardiovascular disease in subjects with abnormal glucose metabolism – The Hoorn StudyDiabetologia2003469101612819906
   PubMed Web of Science ®Google Scholar
• BurchfielCMLawsABenfanteRCombined effects of HDL cholesterol, triglyceride, and total cholesterol concentrations on 18-year risk of atherosclerotic diseaseCirculation199592143067664423
   PubMed Web of Science ®Google Scholar
• CremerPNagelDMannHTen-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 menAtherosclerosis1997129221309105565
   PubMed Web of Science ®Google Scholar
• CriquiMHHeissGCohnRPlasma triglyceride level and mortality from coronary heart diseaseN Engl J Med1993328122058464432
   PubMed Web of Science ®Google Scholar
• D'AgostinoRBRussellMWHuseDMPrimary and subsequent coronary risk appraisal: new results from the Framingham studyAm Heart J2000139(2 Pt 1):2728110650300
   PubMed Web of Science ®Google Scholar
• DunderKLindLLagerqvistBCardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarctionAm Heart J2004147502814999201
   PubMedGoogle Scholar
• EberlyLEStamlerJNeatonJDRelation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart diseaseArch Intern Med200316310778312742806
   PubMedGoogle Scholar
• FerrarioMChiodiniPChamblessLEPrediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equationInt J Epidemiol2005344132115659467
   PubMed Web of Science ®Google Scholar
• HaimMBenderlyMBrunnerDElevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: the Bezafibrate Infarction Prevention (BIP) RegistryCirculation19991004758210430760
   PubMed Web of Science ®Google Scholar
• HulleySBRosenmanRHBawolRDEpidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart diseaseN Engl J Med1980302138397374696
   PubMed Web of Science ®Google Scholar
• IngelssonEArnlovJSundstromJNovel metabolic risk factors for heart failureJ Am Coll Cardiol20054620546016325042
   PubMedGoogle Scholar
• IsoHNaitoYSatoSSerum triglycerides and risk of coronary heart disease among Japanese men and womenAm J Epidemiol2001153490911226981
   PubMed Web of Science ®Google Scholar
• JeppesenJHeinHOSuadicaniPRelation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male StudyArterioscler Thromb Vasc Biol1997171114209194762
   PubMed Web of Science ®Google Scholar
• JeppesenJHeinHOSuadicaniPTriglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male StudyCirculation1998971029369531248
   PubMed Web of Science ®Google Scholar
• JeppesenJHeinHOSuadicaniPLow triglycerides-high high-density lipoprotein cholesterol and risk of ischemic heart diseaseArch Intern Med2001161361611176761
   PubMedGoogle Scholar
• JiangRSchulzeMBLiTNon-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetesDiabetes Care2004271991715277429
   PubMed Web of Science ®Google Scholar
• LaaskoMLehtoSPenttlaILipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetesCirculation199388(4 Pt 1):1421308403288
   PubMedGoogle Scholar
• LehtoSRonnemaaTHaffnerSMDyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDMDiabetes199746135499231662
   PubMed Web of Science ®Google Scholar
• LuWResnickHEJablonskiKANon-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart studyDiabetes Care200326162312502653
   PubMed Web of Science ®Google Scholar
• MenottiASpagnoloAScangaMMultivariate prediction of coronary deaths in a 10 year follow-up of an Italian occupational male cohortActa Cardiol199247311201523912
   PubMed Web of Science ®Google Scholar
• MenottiAScangaMMorisiGSerum triglycerides in the prediction of coronary artery disease (an Italian experience)Am J Cardiol19947329328279373
   PubMedGoogle Scholar
• MossAJGoldsteinREMarderVJThrombogenic factors and recurrent coronary eventsCirculation19999925172210330382
   PubMed Web of Science ®Google Scholar
• PatelABarziFJamrozikKSerum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific regionCirculation200411026788615492305
   PubMed Web of Science ®Google Scholar
• PirroMMauriegePTchernofAPlasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular StudyAtherosclerosis20021603778411849661
   PubMed Web of Science ®Google Scholar
• PischonTGirmanCJSacksFMNon-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in menCirculation200511233758316316964
   PubMed Web of Science ®Google Scholar
• PsatyBMAndersonMKronmalRAThe association between lipid levels and the risks of incident myocardial infarction, stroke, and total mortality: The Cardiovascular Health StudyJ Am Geriatr Soc20045216394715450039
   PubMed Web of Science ®Google Scholar
• SaitoIFolsomARBrancatiFLNontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) StudyAnn Intern Med2000133819110896647
   PubMedGoogle Scholar
• SchulzeMBShaiIMansonJEJoint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetesDiabetologia20044721293615662553
   PubMed Web of Science ®Google Scholar
• ShaiIRimmEBHankinsonSEMultivariate assessment of lipid parameters as predictors of coronary heart disease among post-menopausal women: potential implications for clinical guidelinesCirculation200411028243015492318
   PubMed Web of Science ®Google Scholar
• SharrettARBallantyneCMCoadySACoronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) StudyCirculation200110411081311535564
   PubMed Web of Science ®Google Scholar
• StampferMJKraussRMMaJA prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarctionJAMA199627688288782637
   PubMed Web of Science ®Google Scholar
• StevensRJKothariVAdlerAIThe UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)Clin Sci (Lond)2001101671911724655
   PubMed Web of Science ®Google Scholar
• TalmudPJHaweEMillerGJNonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK menArterioscler Thromb Vasc Biol20022219182312426225
   PubMed Web of Science ®Google Scholar
• TankoLBBaggerYZQinGEnlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal womenCirculation200511118839015837940
   PubMed Web of Science ®Google Scholar
• WalldiusGJungnerIHolmeIHigh apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective studyLancet200135820263311755609
   PubMed Web of Science ®Google Scholar
• WilsonPWLarsonMGCastelliWPTriglycerides, HDL cholesterol and coronary artery disease: a Framingham update on their interrelationsCan J Cardiol199410Suppl5b9b
   Google Scholar
• YarnellJWPattersonCCSweetnamPMDo total and high density lipoprotein cholesterol and triglycerides act independently in the prediction of ischemic heart disease? Ten-year follow-up of Caerphilly and Speedwell CohortsArterioscler Thromb Vasc Biol2001211340511498463
   PubMed Web of Science ®Google Scholar
• YuSYarnellJWSweetnamPHigh density lipoprotein subfractions and the risk of coronary heart disease: 9-years follow-up in the Caerphilly StudyAtherosclerosis2003166331812535746
   PubMed Web of Science ®Google Scholar
• NordestgaardBGBennMSchnohrPNonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and womenJAMA200729829930817635890
   PubMed Web of Science ®Google Scholar
• TiroshARudichAShochatTChanges in triglyceride levels and risk for coronary heart disease in young menAnn Intern Med20071473778517876021
   PubMed Web of Science ®Google Scholar
• BansalSBuringJERifaiNFasting compared with nonfasting triglycerides and risk of cardiovascular events in womenJAMA20072983091617635891
   PubMed Web of Science ®Google Scholar
• DunderKLindLZetheliusBEvaluation of a scoring scheme, including proinsulin and the apolipoprotein B/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala Longitudinal Study of Adult Men (ULSAM)Am Heart J200414859660115459588
   PubMed Web of Science ®Google Scholar
• SweetnamPMBoltonCHDownsLGApolipoproteins A-I, A-II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly studyEur J Clin Invest2000309475611114956
   PubMedGoogle Scholar
• DespresJPLemieuxIDagenaisGRHDL-cholesterol as a marker of coronary heart disease risk: the Quebec cardiovascular studyAtherosclerosis20001532637211164415
   PubMed Web of Science ®Google Scholar
• SarwarNDaneshJEiriksdottirGTriglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studiesCirculation2007115450817190864
   PubMed Web of Science ®Google Scholar
• DaneshJCollinsRApplebyPAssociation of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studiesJAMA19982791477829600484
   PubMed Web of Science ®Google Scholar
• BirjmohunRSHuttenBAKasteleinJJEfficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trialsJ Am Coll Cardiol2005451859715653014
   PubMed Web of Science ®Google Scholar
• EdwardsJEMooreRAStatins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trialsBMC Fam Pract200341814969594
   PubMedGoogle Scholar
• LawMRWaldNJRudnickaARQuantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysisBMJ2003326142312829554
   PubMed Web of Science ®Google Scholar
• DavidsonMHMcKenneyJMShearCLEfficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levelsJ Am Col Cardiol200648177481
   PubMed Web of Science ®Google Scholar
• BaysHEMcKenneyJMDujovneCAEffectiveness and tolerability of a new lipid-altering agent, gemcabene, in patients with low levels of high-density lipoprotein cholesterolAm J Cardiol2003925384312943873
   PubMed Web of Science ®Google Scholar
• OramJFTangier disease and ABCA1Biochim Biophys Acta200015291–33213011111099
   PubMed Web of Science ®Google Scholar
• BenlianPEtienneJde GennesJLHomozygous deletion of exon 9 causes lipoprotein lipase deficiency: possible intron-Alu recombinationJ Lipid Res199536356667751824
   PubMedGoogle Scholar
• BenlianPDe GennesJLFoubertLPremature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase geneN Engl J Med1996335848548778602
   PubMed Web of Science ®Google Scholar
• HokansonJEFunctional variants in the lipoprotein lipase gene and risk cardiovascular diseaseCurr Opin Lipidol199910393910554701
   PubMed Web of Science ®Google Scholar
• WittrupHHTybjaerg-HansenANordestgaardBGLipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysisCirculation1999992901710359734
   PubMed Web of Science ®Google Scholar
• ThornJANeedhamEWMattuRKThe Ser447-Ter mutation of the lipoprotein lipase gene relates to variability of serum lipid and lipoprotein levels in monozygotic twinsJ Lipid Res199839437419508003
   PubMedGoogle Scholar
• GagneSELarsonMGPimstoneSNA common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring StudyClin Genet199955450410450862
   PubMed Web of Science ®Google Scholar
• BreckenridgeWCLittleJAAlaupovicPLipoprotein abnormalities associated with a familial deficiency of hepatic lipaseAtherosclerosis198245161796961921
   PubMed Web of Science ®Google Scholar
• HegeleRALittleJAVezinaCHepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristicsArterioscler Thromb19931372088485124
   PubMedGoogle Scholar
• JiJHerbisonCEMamotteCDHepatic lipase gene -514 C/T polymorphism and premature coronary heart diseaseJ Cardiovasc Risk200291051312006918
   PubMedGoogle Scholar
• HokansonJEKambohMIScarboroSEffects of the hepatic lipase gene and physical activity on coronary heart disease riskAm J Epidemiol20031588364314585761
   PubMedGoogle Scholar
• RuelILCouturePCohnJSEvidence that hepatic lipase deficiency in humans is not associated with proatherogenic changes in HDL composition and metabolismJ Lipid Res20044515283715175359
   PubMedGoogle Scholar